ArcBest ARCB 深 沪
等待开盘 09-04 09:30:00 美东时间
137.34
+3.410
+2.55%
华盛通- 最 高137.57
- 今 开134.84
- 成交量 18.01万股
- 最 低 130.92
- 昨 收 133.93
- 总市值 30.70亿
- 52周最高 176.5657
- 市盈率 静 52.41
- 换手率 0.81%
- 52周最低 59.07
- 委 比 10.71%
- 总股本 2235.14万
- 历史最高 176.5657
- 量 比 0.84
- 振 幅 4.97%
- 历史最低 1.98
- 每 手 1
- 风险率 31.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Industrials take top overweight spot: Ten stocks stand out on Quant ratings
With Industrials emerging as the largest overweight sector among U.S. funds, according to Variant Perception, attention is turning to individual companies that stand out within the space. As of Aug. 2...
08-31 22:46
Full steam ahead: The Union Pacific-Norfolk Southern merger review is moving forward
The Surface Transportation Board restarted its review of Union Pacific's (UNP) proposed merger with Norfolk Southern (NSC). Notably, the board had paused the case while it asked the companies for more...
08-19 22:02
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
TD Cowen Maintains Hold on ArcBest, Lowers Price Target to $155
TD Cowen analyst Jason H. Seidl maintains ArcBest (NASDAQ:ARCB) with a Hold and lowers the price target from $175 to $155.
07-30 23:37
ArcBest shares are trading lower. The company reported its Q2 financial results.
ArcBest shares are trading lower. The company reported its Q2 financial results.
07-29 22:55
财报速睇 | ArcBest 2026财年Q2营收11.85亿美元，同比增长15.9%；归母净利润亏损0.14亿美元，由盈转亏
华盛资讯7月29日讯，ArcBest公布2026财年Q2业绩，公司Q2营收11.85亿美元，同比增长15.9%，归母净利润亏损0.14亿美元，由盈转亏。
07-29 18:29
ArcBest Q2 Adj. EPS $2.38 Beats $2.27 Estimate, Sales $1.185B Beat $1.166B Estimate
ArcBest (NASDAQ:ARCB) reported quarterly earnings of $2.38 per share which beat the analyst consensus estimate of $2.27 by 4.85 percent. This is a 75 percent increase over earnings of $1.36 per share from the same period last year. The company reported quarterly sales of $1.185 billion which beat th...
07-29 18:03
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
ArcBest announces restructuring and brand simplification initiative
The latest announcement is out from ArcBest ( ($ARCB) ). On July 16, 2026, ArcB...
07-17 17:14
